Yesterday, Dec. 2, 2015, 106 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $37.00 to $104,114,531.25.

Highlighted Stocks Traded by Insiders:

Maximus (MMS) - FREE Research Report

Beliveau Russell A, who is Director at Maximus, sold 1,000 shares at $56.81 on Dec. 2, 2015. Following this transaction, the Director owned 45,579 shares meaning that the stake was reduced by 2.15% with the 1,000-share transaction.

The shares most recently traded at $57.80, up $0.99, or 1.71% since the insider transaction. Historical insider transactions for Maximus go as follows:

  • 4-Week # shares bought: 15,375
  • 4-Week # shares sold: 20,000
  • 12-Week # shares bought: 15,375
  • 12-Week # shares sold: 20,000
  • 24-Week # shares bought: 15,375
  • 24-Week # shares sold: 21,000

The average volume for Maximus has been 481,100 shares per day over the past 30 days. Maximus has a market cap of $3.7 billion and is part of the services sector and diversified services industry. Shares are up 4.85% year-to-date as of the close of trading on Wednesday.

MAXIMUS, Inc. provides business process services (BPS) to government health and human services in the United States, the United Kingdom, Australia, Canada, Saudi Arabia, and New Zealand. The stock currently has a dividend yield of 0.32%. The company has a P/E ratio of 24.2. Currently, there are 4 analysts who rate Maximus a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MMS - FREE

TheStreet Quant Ratings

rates Maximus as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Maximus Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Photronics (PLAB) - FREE Research Report

Tyson Mitchell G, who is Director at Photronics, sold 1,000 shares at $10.95 on Dec. 2, 2015. Following this transaction, the Director owned 67,579 shares meaning that the stake was reduced by 1.46% with the 1,000-share transaction.

The shares most recently traded at $11.66, up $0.71, or 6.13% since the insider transaction. Historical insider transactions for Photronics go as follows:

  • 4-Week # shares bought: 10,332
  • 4-Week # shares sold: 1,000
  • 12-Week # shares bought: 10,332
  • 12-Week # shares sold: 2,000
  • 24-Week # shares bought: 10,332
  • 24-Week # shares sold: 7,000

The average volume for Photronics has been 338,700 shares per day over the past 30 days. Photronics has a market cap of $738.5 million and is part of the technology sector and electronics industry. Shares are up 34.18% year-to-date as of the close of trading on Wednesday.

Photronics, Inc., together with its subsidiaries, manufactures and sells photomasks in the United States. Photomasks are high precision photographic quartz plates containing microscopic images of electronic circuits. The company has a P/E ratio of 25.1. Currently, there are 3 analysts who rate Photronics a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PLAB - FREE

TheStreet Quant Ratings

rates Photronics as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full

Photronics Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Electro Scientific Industries (ESIO) - FREE Research Report

Mustoe Kerry L, who is VP, Corporate Controller & CAO at Electro Scientific Industries, sold 6,502 shares at $5.05 on Dec. 2, 2015. Following this transaction, the VP, Corporate Controller & CAO owned 39,378 shares meaning that the stake was reduced by 14.17% with the 6,502-share transaction.

The shares most recently traded at $5.08, up $0.03, or 0.59% since the insider transaction. Historical insider transactions for Electro Scientific Industries go as follows:

  • 4-Week # shares bought: 4,000
  • 4-Week # shares sold: 21,181
  • 12-Week # shares bought: 4,000
  • 12-Week # shares sold: 21,181
  • 24-Week # shares bought: 49,000
  • 24-Week # shares sold: 21,181

The average volume for Electro Scientific Industries has been 80,800 shares per day over the past 30 days. Electro Scientific Industries has a market cap of $156.4 million and is part of the technology sector and electronics industry. Shares are down 34.92% year-to-date as of the close of trading on Wednesday.

Electro Scientific Industries, Inc., together with its subsidiaries, supplies laser-based manufacturing solutions for the microtechnology industry worldwide. The company operates in two segments, Component Processing and Micromachining. The stock currently has a dividend yield of 5.81%. Currently, there is 1 analyst who rates Electro Scientific Industries a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ESIO - FREE

TheStreet Quant Ratings

rates Electro Scientific Industries as a

sell

. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity and generally disappointing historical performance in the stock itself. Get the full

Electro Scientific Industries Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.